JPH01503069A - 新規な医薬化合物 - Google Patents

新規な医薬化合物

Info

Publication number
JPH01503069A
JPH01503069A JP63503532A JP50353288A JPH01503069A JP H01503069 A JPH01503069 A JP H01503069A JP 63503532 A JP63503532 A JP 63503532A JP 50353288 A JP50353288 A JP 50353288A JP H01503069 A JPH01503069 A JP H01503069A
Authority
JP
Japan
Prior art keywords
tables
formulas
formula
chemical formulas
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63503532A
Other languages
English (en)
Japanese (ja)
Inventor
ダテーマ，ロエルフ
コヴアクス，スサンナ・マリア・イローナ
ヨハンソン，カール・ニルス・グンナー
リンドボルイ，ビヨルン・グンナー
ステニング，イヨーラン・ベルテイル
オヨーベルイ，ブー・フレドリーク
Original Assignee
メディヴイル・アクチエボラーグ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メディヴイル・アクチエボラーグ filed Critical メディヴイル・アクチエボラーグ
Publication of JPH01503069A publication Critical patent/JPH01503069A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP63503532A 1987-04-16 1988-04-06 新規な医薬化合物 Pending JPH01503069A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8701605-1 1987-04-16
SE8701605A SE8701605D0 (sv) 1987-04-16 1987-04-16 Novel medicinal compounds
CA000580141A CA1336088C (fr) 1987-04-16 1988-10-14 1- (3'-substituant-2', 3'-didesoxy-d-ribofuranosyl) thymine et uracile

Publications (1)

Publication Number Publication Date
JPH01503069A true JPH01503069A (ja) 1989-10-19

Family

ID=25672174

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63503532A Pending JPH01503069A (ja) 1987-04-16 1988-04-06 新規な医薬化合物

Country Status (9)

Country Link
JP (1) JPH01503069A (fr)
AT (1) ATE115958T1 (fr)
AU (1) AU614082B2 (fr)
CA (1) CA1336088C (fr)
DE (1) DE3852531T2 (fr)
DK (3) DK168443B1 (fr)
HU (1) HU211547A9 (fr)
SE (1) SE8701605D0 (fr)
WO (1) WO1988008001A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014109384A1 (fr) * 2013-01-10 2014-07-17 塩野義製薬株式会社 Procédé de production de dérivé d'acide nucléique réticulé

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629892D0 (en) * 1986-12-15 1987-01-28 Wellcome Found Antiviral compounds
US4950758A (en) * 1988-01-20 1990-08-21 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
AU631119B2 (en) * 1988-02-24 1992-11-19 Institut De Recherches Chimiques Et Biologiques Appliquees (I.R.C.E.B.A.) New derivatives of deoxy-2'-uridine substituted in the 5,3' or 5' position by acylated alpha-amino groups, process for obtaining them and drugs containing them
US7119202B1 (en) 1989-02-08 2006-10-10 Glaxo Wellcome Inc. Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties
US5157114A (en) * 1988-08-19 1992-10-20 Burroughs Wellcome Co. 2',3'-dideoxy-3'-fluoro-5-ethyngluridine
US5198539A (en) * 1988-08-19 1993-03-30 Burroughs Wellcome Co. 5'-esters of 2',3'-dideoxy-3'-fluoro-5-ethynyluridine
FI95384C (fi) * 1989-04-06 1996-01-25 Squibb Bristol Myers Co Menetelmä 3'-deoksi-3'-substituoitujen metyylinukleosidien valmistamiseksi ja menetelmässä käytettäviä välituotteita
FR2648045B1 (fr) * 1989-06-13 1991-09-27 Centre Nat Rech Scient Composes oligonucleotidiques anomeres alpha inhibant la replication des retrovirus
IE902574A1 (en) * 1989-07-17 1991-02-27 Univ Birmingham Antiviral pyrimidine nucleosides
US5591722A (en) * 1989-09-15 1997-01-07 Southern Research Institute 2'-deoxy-4'-thioribonucleosides and their antiviral activity
AU6401490A (en) * 1989-09-15 1991-04-18 Southern Research Institute 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents
US5728575A (en) 1990-02-01 1998-03-17 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
GB9008696D0 (en) * 1990-04-18 1990-06-13 Wellcome Found Anti-viral compounds
US5521163A (en) * 1990-07-13 1996-05-28 University Of Birmingham Antiviral pyrimidine nucleosides and methods for using same
SE9003151D0 (sv) * 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
US5587480A (en) * 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
US6228860B1 (en) 1990-11-13 2001-05-08 Biochem Pharma Inc. Substituted 1,3-oxathiolanes with antiviral properties
US6369066B1 (en) 1990-11-13 2002-04-09 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes with antiviral properties
DK0560794T3 (da) * 1990-11-13 1996-12-23 Iaf Biochem Int Substituerede 1,3-oxathiolaner med antivirale egenskaber
AU3222793A (en) * 1991-11-26 1993-06-28 Gilead Sciences, Inc. Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
US6235887B1 (en) 1991-11-26 2001-05-22 Isis Pharmaceuticals, Inc. Enhanced triple-helix and double-helix formation directed by oligonucleotides containing modified pyrimidines
TW393513B (en) * 1991-11-26 2000-06-11 Isis Pharmaceuticals Inc Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
US20020120130A1 (en) 1993-09-10 2002-08-29 Gilles Gosselin 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
AU697612B2 (en) * 1994-05-31 1998-10-15 Medivir Ab Post exposure prevention of HIV
US5612319A (en) * 1994-05-31 1997-03-18 Medivir Ab Postexposure prevention of HIV infection or seroconversion
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
PT831852E (pt) 1995-06-07 2007-02-28 Uab Research Foundation Nucleósidos com actividade anti-vírus da hepatite b
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US5753789A (en) * 1996-07-26 1998-05-19 Yale University Oligonucleotides containing L-nucleosides
WO1999043691A1 (fr) 1998-02-25 1999-09-02 Emory University 2'-fluoronucleosides
WO2002032920A2 (fr) 2000-10-18 2002-04-25 Pharmasset Limited Nucleosides modifies pour traiter des infections virales et une proliferation cellulaire anormale
AP2009004812A0 (en) 2006-10-10 2009-04-30 Medivir Ab HCV nucleoside inhibitor

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD75084A (fr) *
US3116282A (en) * 1960-04-27 1963-12-31 Upjohn Co Pyrimidine nucleosides and process
FR2040177A1 (en) * 1969-01-31 1971-01-22 Robugen Gmbh 2-deoxyribosyl-uracil derivs
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
DE2918260A1 (de) * 1979-05-07 1980-11-27 Robugen Gmbh Anwendung von 5-alkyl-2'-desoxyuridinen
US4267171A (en) * 1979-07-02 1981-05-12 The Regents Of The University Of California C-5 Substituted cytosine nucleosides
US4247544A (en) * 1979-07-02 1981-01-27 The Regents Of The University Of California C-5 Substituted uracil nucleosides
DE2930904A1 (de) * 1979-07-30 1981-02-19 Kailash Kumar Dr Gauri Verwendung von 5-alkyl-pyrimidinnucleosiden bei der bekaempfung von krebs
DE3002197A1 (de) * 1980-01-22 1981-07-23 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen 5-alkylsubstituierte pyrimidin-nukleoside, verfahren zu deren herstellung und daraus hergestellte virostatische und cytostatische mittel
DE3045375A1 (de) * 1980-12-02 1982-07-01 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Neue substituierte pyrimidin-nukleoside mit antiviraler wirkung, verfahren zu deren herstellung und daraus zubereitete arzneiformen
DE3229169A1 (de) * 1982-08-05 1984-02-09 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Verwendung von 5-alkylpyrimidinnukleosiden und deren derivate als zytostatika
IE73219B1 (en) * 1985-03-16 1997-05-07 Wellcome Found Therapeutic nucleosides
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
ATE113603T1 (de) * 1985-03-16 1994-11-15 Wellcome Found Antivirale nukleoside.
ES8801303A1 (es) * 1985-05-15 1987-12-16 Wellcome Found Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
DE3650741T2 (de) * 1985-09-17 2000-10-12 The Wellcome Foundation Ltd., Greenford Kombination therapeutische Nukleoside mit weiteren therapeutisch wirksamen Komponenten.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014109384A1 (fr) * 2013-01-10 2014-07-17 塩野義製薬株式会社 Procédé de production de dérivé d'acide nucléique réticulé
JPWO2014109384A1 (ja) * 2013-01-10 2017-01-19 塩野義製薬株式会社 架橋型核酸誘導体の製造方法

Also Published As

Publication number Publication date
DE3852531D1 (de) 1995-02-02
DK108491A (da) 1991-06-07
AU1689988A (en) 1988-11-04
HU211547A9 (en) 1995-12-28
WO1988008001A1 (fr) 1988-10-20
DK696988D0 (da) 1988-12-15
DK104994A (da) 1994-09-13
SE8701605D0 (sv) 1987-04-16
DK108491D0 (da) 1991-06-07
ATE115958T1 (de) 1995-01-15
DK168443B1 (da) 1994-03-28
CA1336088C (fr) 1995-06-27
DK696988A (da) 1989-01-31
AU614082B2 (en) 1991-08-22
DE3852531T2 (de) 1995-08-10

Similar Documents

Publication Publication Date Title
JPH01503069A (ja) 新規な医薬化合物
JP2851094B2 (ja) ピリミジン誘導体
US5830898A (en) Enantiomerically pure β-di-dioxolane-nucleosides with selective anti-hepatitis B virus activity
JPH01151595A (ja) 治療に使用するための化合物
US5587362A (en) L-nucleosides
US5952500A (en) Nucleoside derivatives
PT91213A (pt) Processo para a preparacao de novos analogos nucleosidicos de l-ribofuranosilo com actividade terapeutica
JPH0780898B2 (ja) 抗ウイルスヌクレオシド
US5215971A (en) Antiviral pharmaceutical composition comprising 5-substituted pyrimidine nucleosides
US5215970A (en) Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
JPS61257925A (ja) 抗ウイルスヌクレオシド
JPH04501867A (ja) 抗ウィルス剤としての５´―アルキルホスホニルヌクレオシド
EP0516186A2 (fr) Nucléosides et analogues de nucléosides, compositions et procédés pharamaceutiques permettant la préparation des composés
EP0309560A1 (fr) Nucleosides et analogues de nucleosides, compositions et procedes pharmaceutiques permettant la preparation des composes.
IE67037B1 (en) Novel medicinal compounds
HU205089B (en) Process for producing new thymine derivatives and pharmaceutical compositions comprising same
HK1014663B (en) Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitis b virus activity
JPH04173787A (ja) 新規抗ウイルス剤及びその製造方法